vs

Side-by-side financial comparison of InMed Pharmaceuticals Inc. (INM) and Ocean Power Technologies, Inc. (OPTT). Click either name above to swap in a different company.

InMed Pharmaceuticals Inc. is the larger business by last-quarter revenue ($820.2K vs $424.0K, roughly 1.9× Ocean Power Technologies, Inc.). InMed Pharmaceuticals Inc. runs the higher net margin — -247.3% vs -2553.1%, a 2305.8% gap on every dollar of revenue. On growth, InMed Pharmaceuticals Inc. posted the faster year-over-year revenue change (-26.2% vs -82.5%). Over the past eight quarters, InMed Pharmaceuticals Inc.'s revenue compounded faster (-16.4% CAGR vs -51.4%).

Teva Pharmaceutical Industries Ltd. is an Israeli multinational pharmaceutical company. Teva specializes primarily in generic drugs, but other business interests include branded-drugs, active pharmaceutical ingredients (APIs) and, to a lesser extent, contract manufacturing services and an out-licensing platform.

Ocean Power Technologies (OPT) is a U.S. publicly owned renewable energy company, providing electric power and communications solutions, services and related for remote offshore applications. The company's PowerBuoy wave energy conversion technology is theoretically scalable to hundreds of megawatts and the generated energy from wave power can be supplied to the grid via submarine cables. Several projects were undertaken around the world, but the economic viability of the theoretical concept ...

INM vs OPTT — Head-to-Head

Bigger by revenue
INM
INM
1.9× larger
INM
$820.2K
$424.0K
OPTT
Growing faster (revenue YoY)
INM
INM
+56.2% gap
INM
-26.2%
-82.5%
OPTT
Higher net margin
INM
INM
2305.8% more per $
INM
-247.3%
-2553.1%
OPTT
Faster 2-yr revenue CAGR
INM
INM
Annualised
INM
-16.4%
-51.4%
OPTT

Income Statement — Q2 FY2026 vs Q2 FY2026

Metric
INM
INM
OPTT
OPTT
Revenue
$820.2K
$424.0K
Net Profit
$-2.0M
$-10.8M
Gross Margin
22.5%
-325.5%
Operating Margin
-247.3%
-2387.5%
Net Margin
-247.3%
-2553.1%
Revenue YoY
-26.2%
-82.5%
Net Profit YoY
21.2%
-176.6%
EPS (diluted)
$-0.51
$-0.06

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
INM
INM
OPTT
OPTT
Q4 25
$820.2K
$424.0K
Q3 25
$1.1M
$1.2M
Q2 25
$1.3M
$1.3M
Q1 25
$1.3M
$825.0K
Q4 24
$1.1M
$2.4M
Q3 24
$1.3M
$1.3M
Q2 24
$1.3M
$1.6M
Q1 24
$1.2M
$1.8M
Net Profit
INM
INM
OPTT
OPTT
Q4 25
$-2.0M
$-10.8M
Q3 25
$-1.7M
$-7.4M
Q2 25
$-1.8M
$-6.4M
Q1 25
$-2.1M
$-6.7M
Q4 24
$-2.6M
$-3.9M
Q3 24
$-1.7M
$-4.5M
Q2 24
$-1.9M
$-6.7M
Q1 24
$-1.7M
$-6.5M
Gross Margin
INM
INM
OPTT
OPTT
Q4 25
22.5%
-325.5%
Q3 25
36.0%
-1.9%
Q2 25
44.2%
16.8%
Q1 25
13.9%
23.9%
Q4 24
41.5%
32.9%
Q3 24
39.0%
34.4%
Q2 24
36.3%
54.8%
Q1 24
24.7%
45.4%
Operating Margin
INM
INM
OPTT
OPTT
Q4 25
-247.3%
-2387.5%
Q3 25
-154.2%
-598.8%
Q2 25
-137.1%
-563.6%
Q1 25
-168.1%
-712.1%
Q4 24
-231.6%
-161.9%
Q3 24
-132.7%
-343.8%
Q2 24
-150.5%
-430.3%
Q1 24
-146.9%
-430.0%
Net Margin
INM
INM
OPTT
OPTT
Q4 25
-247.3%
-2553.1%
Q3 25
-154.2%
-625.0%
Q2 25
-137.1%
-487.9%
Q1 25
-168.1%
-814.5%
Q4 24
-231.6%
-161.8%
Q3 24
-132.7%
-342.3%
Q2 24
-151.0%
-427.6%
Q1 24
-146.9%
-363.2%
EPS (diluted)
INM
INM
OPTT
OPTT
Q4 25
$-0.51
$-0.06
Q3 25
$-0.44
$-0.04
Q2 25
$-0.07
$-0.04
Q1 25
$-1.94
$-0.04
Q4 24
$-3.64
$-0.04
Q3 24
$-2.71
$-0.05
Q2 24
$2.39
$-0.12
Q1 24
$-3.58
$-0.11

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
INM
INM
OPTT
OPTT
Cash + ST InvestmentsLiquidity on hand
$7.0M
$11.7M
Total DebtLower is stronger
Stockholders' EquityBook value
$9.6M
$22.3M
Total Assets
$11.2M
$39.3M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
INM
INM
OPTT
OPTT
Q4 25
$7.0M
$11.7M
Q3 25
$9.4M
$9.9M
Q2 25
$11.1M
$6.7M
Q1 25
$4.7M
$10.0M
Q4 24
$3.5M
$2.1M
Q3 24
$5.6M
$3.2M
Q2 24
$6.6M
$3.2M
Q1 24
$9.1M
Stockholders' Equity
INM
INM
OPTT
OPTT
Q4 25
$9.6M
$22.3M
Q3 25
$11.6M
$24.2M
Q2 25
$13.4M
$26.7M
Q1 25
$7.0M
$28.9M
Q4 24
$6.2M
$22.1M
Q3 24
$8.4M
$22.3M
Q2 24
$9.2M
$19.3M
Q1 24
$11.1M
$25.3M
Total Assets
INM
INM
OPTT
OPTT
Q4 25
$11.2M
$39.3M
Q3 25
$13.4M
$36.6M
Q2 25
$15.6M
$30.8M
Q1 25
$9.3M
$34.4M
Q4 24
$8.5M
$26.9M
Q3 24
$10.5M
$29.2M
Q2 24
$11.8M
$28.7M
Q1 24
$34.6M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
INM
INM
OPTT
OPTT
Operating Cash FlowLast quarter
$-2.4M
$-7.5M
Free Cash FlowOCF − Capex
$-7.8M
FCF MarginFCF / Revenue
-1838.9%
Capex IntensityCapex / Revenue
62.7%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-23.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
INM
INM
OPTT
OPTT
Q4 25
$-2.4M
$-7.5M
Q3 25
$-1.6M
$-5.6M
Q2 25
$-1.8M
$-4.0M
Q1 25
$-1.7M
$-3.7M
Q4 24
$-2.5M
$-4.8M
Q3 24
$-1.8M
$-6.1M
Q2 24
$-1.0M
$-5.1M
Q1 24
$-1.9M
$-9.2M
Free Cash Flow
INM
INM
OPTT
OPTT
Q4 25
$-7.8M
Q3 25
$-7.1M
Q2 25
$-4.2M
Q1 25
$-4.0M
Q4 24
$-5.0M
Q3 24
$-6.5M
Q2 24
$-6.4M
Q1 24
$-1.9M
$-9.7M
FCF Margin
INM
INM
OPTT
OPTT
Q4 25
-1838.9%
Q3 25
-597.1%
Q2 25
-315.9%
Q1 25
-480.0%
Q4 24
-207.3%
Q3 24
-499.5%
Q2 24
-408.0%
Q1 24
-165.0%
-543.6%
Capex Intensity
INM
INM
OPTT
OPTT
Q4 25
62.7%
Q3 25
122.9%
Q2 25
11.8%
Q1 25
26.9%
Q4 24
10.2%
Q3 24
28.7%
Q2 24
86.6%
Q1 24
0.0%
29.4%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons